Robert Califf's term as FDA commissioner could be defined by what he must do, rather than what he wants to do.
Confirmed by an 89-4 Senate vote on Feb. 24, Califf takes over the agency from acting commissioner Stephen Ostroff, who is expected to remain in the Office of the Commissioner...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?